Title:
COMPOSITION SUITABLE FOR USE AS RS VIRUS VACCINE
Document Type and Number:
WIPO Patent Application WO/2024/084785
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide a composition having higher efficacy and safety and suitable for use as a RS virus vaccine. Provided is a composition containing G protein and a CpG oligodeoxynucleotide of a RS virus, in which the G protein does not have a modified sugar chain of a mammalian cell-expressed type.
Inventors:
YOSHIOKA YASUO (JP)
SHIBATA TAKEHIKO (JP)
SHIBATA TAKEHIKO (JP)
Application Number:
PCT/JP2023/029100
Publication Date:
April 25, 2024
Filing Date:
August 09, 2023
Export Citation:
Assignee:
UNIV OSAKA RES FOUND FOR MICROBIAL DISEASES (JP)
UNIV TOKYO MEDICAL (JP)
UNIV TOKYO MEDICAL (JP)
International Classes:
A61K38/02; A61K9/08; A61K9/20; A61K31/7088; A61K39/155; A61K48/00; A61P11/00; A61P37/04; A61P43/00; C07K14/08; C12N15/117; C12N15/40
Domestic Patent References:
| WO2002058725A2 | 2002-08-01 | |||
| WO2015041318A1 | 2015-03-26 |
Foreign References:
| JP2005511010A | 2005-04-28 | |||
| JPH03502687A | 1991-06-20 | |||
| US20210113683A1 | 2021-04-22 |
Other References:
CHU, R S et al. CpG Oligodeoxynucleotides Act as Adjuvants that Switch on T Helper 1 (Th1) Immunity. J Exp Med. 1997, vol. 186, no. 10, pp. 1623-1631
Attorney, Agent or Firm:
SAEGUSA & PARTNERS (JP)
Download PDF: